Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-4gq6khrPhase 4Not yet recruiting
Phase 4, randomised, open-label trial of amoxicillin and metronidazole in Aggressive Periodontitis (AP), sponsored by Universidade Federal do Rio Grande do Norte. Planned start Dec 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-4gq6khr.